Hyperion DeFi (HYPD) Stock: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$3.73
0.07 (1.91%)
▲
5d:
-7.67%
30d:
+21.9%
90d:
+14.42%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HYPD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HYPD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.49
Based on -30.7% avg growth
INTRINSIC VALUE TODAY
$0.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $3.73, which is considered extended relative to its 30-day fair value range of $3.28 to $3.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.5) compared to its historical average (5.5). Remarkably, the market is currently pricing in an annual earnings decline of 34.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HYPD is showing sideways momentum. The price is currently testing key support at $3.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HYPD scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.82 (+163.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HYPD is showing sideways momentum. The price is currently testing key support at $3.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HYPD scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.82 (+163.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.28 -
$3.90
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
28.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 163.4% below Wall St target ($9.82)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.28 -
$3.90
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.64
Resistance Level
$4.17
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.54
Wall Street Target
$9.83
(+163.4%)
Revenue Growth (YoY)
1559.5%
Profit Margin
474.9%
Valuation Discount vs History
-34.6% cheaper
PE vs Historical
1.5 vs 5.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-34.6%
(market-implied from PE analysis)
1-Year Target
$3.36
(-10%)
2-Year Target
$3.02
(-19%)
3-Year Target
$2.72
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→6)
$9.70
(+160%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: -65.4%)
$35.99
(+865%)
Base:
(SPY PE: 1.5, Growth: -65.4%)
$2.72
(-27%)
Bear:
(PE: 1.3, Growth: -65.4%)
$2.31
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.5 to 5.5
Stabilization Target:
$13.31
(+256.8%)
PE Expansion Potential:
+256.8%
Share & Embed Analysis
Last updated: October 03, 2026 2:42 PM ET
Data refreshes hourly during market hours. Next update: 3:42 PM
Data refreshes hourly during market hours. Next update: 3:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
